Cerebrospinal Fluid Profile of Amyloid β Peptides in Patients with Alzheimer’s Disease Determined by Protein Biochip Technology

Publisher： Karger

E-ISSN： 1660-2862|1|4-5|231-235

ISSN： 1660-2854

Source： Neurodegenerative Diseases, Vol.1, Iss.4-5, 2004-11, pp. : 231-235

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Prediction of Alzheimer’s Disease Using a Cerebrospinal Fluid Pattern of C-Terminally Truncated β-Amyloid Peptides

By  

Neurodegenerative Diseases, Vol. 5, Iss. 5, 2008-02 ,pp. : 268-276

Karger

Access to resources Recommend Favorite

S-Adenosylmethionine Is Decreased in the Cerebrospinal Fluid of Patients with Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 6, 2010-06 ,pp. : 373-378

Karger

Access to resources Recommend Favorite

Relative Ratio and Level of Amyloid-β 42 Surrogate in Cerebrospinal Fluid of Familial Alzheimer Disease Patients with Presenilin 1 Mutations

By  

Neurodegenerative Diseases, Vol. 13, Iss. 2-3, 2013-10 ,pp. : 166-170

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Concentrations of Functionally Important Amino Acids and Metabolic Compounds in Patients with Mild Cognitive Impairment and Alzheimer’s Disease

By  

Neurodegenerative Diseases, Vol. 7, Iss. 4, 2010-05 ,pp. : 251-259

Karger

Access to resources Recommend Favorite

Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease Families with PSEN1 Mutations

By  

Neurodegenerative Diseases, Vol. 8, Iss. 4, 2011-01 ,pp. : 202-207

Karger

Access to resources Recommend Favorite